Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic nephropathy.

G Boner1, M E Cooper

  • 1Department of Medicine, University of Melbourne, Austin and Repatriation Medical Center (Repatriation Campus), West Heidelberg, Australia.

Diabetes Technology & Therapeutics
|July 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.

Journal of endocrinological investigation·2021
Same author

Dental Decay Phenotype in Nonsyndromic Orofacial Clefting.

Journal of dental research·2017
Same author

Spectrum of Dental Phenotypes in Nonsyndromic Orofacial Clefting.

Journal of dental research·2015
Same author

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice.

Diabetologia·2013
Same author

Fine-mapping of 5q12.1-13.3 unveils new genetic contributors to caries.

Caries research·2013
Same author

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.

Diabetologia·2013
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles

Diabetic nephropathy, a major complication of diabetes, causes end-stage renal failure. Intensive glycemic and blood pressure control, alongside lifestyle changes, significantly advances prevention and treatment.

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic nephropathy is a leading cause of end-stage renal failure in type 1 and type 2 diabetes mellitus.
  • It significantly increases morbidity and mortality compared to other renal diseases.
  • Pathogenesis involves metabolic and hemodynamic factors.

Purpose of the Study:

  • To summarize current understanding and management of diabetic nephropathy.
  • To highlight the importance of risk factor screening and intensive management.

Main Methods:

  • Review of established guidelines and therapeutic measures for diabetic nephropathy.
  • Emphasis on glycemic control, blood pressure management, and lifestyle interventions.

Main Results:

Related Experiment Videos

  • Intensive glycemic control and hypertension treatment have shown significant advances in preventing diabetic nephropathy progression.
  • Regular screening for risk factors is crucial for early detection and intervention.

Conclusions:

  • Effective management of hyperglycemia and hypertension is key in diabetic nephropathy treatment.
  • Ancillary measures like lipid management, low-protein diet, and smoking cessation are important.
  • Proactive patient screening and adherence to guidelines are essential for managing diabetic kidney disease.